Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Maguire, Maureen G., Martin, Daniel F., Ying, Gui-shuang, Jaffe, Glenn J., Daniel, Ebenezer, Grunwald, Juan E., Toth, Cynthia A., Ferris, Frederick L., Fine, Stuart L.·2016·Ophthalmology

DOI 10.1016/j.ophtha.2016.03.045

Cited by (706)

Items 501–600 of 706

Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy
Giulia Scondotto, Janet Sultana, Maria Vadalà, Teresio Avitabile, Salvatore Cillino, Saveria Serena Foti, Luca L’Abbate, Antonio Longo, Eliana Mirabelli, Maria Rosalia Puzo et al. · 2022 · European Journal of Ophthalmology
A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study
ALEXANDROS A. ROUVAS, Ioannis Datseris, Sofia N. Androudi, Miltiadis K. Tsilimbaris, Stamatina A. Kabanarou, Nikolaos M. Pharmakakis, Chryssanthi Koutsandrea, Alexander C. Charonis, Olga Ch. Kousidou, Γεωργία Παντελοπούλου · 2022 · Clinical ophthalmology
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration
Gary C. Brown, Melissa M. Brown, Dennis L. Gierhart, R. Joseph Olk · 2023 · Ophthalmology and Therapy
A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously
Linlin Kong, Fangjie Liu, Linan Huo, Chunjie Sha, Wanhui Liu, Fei Yu · 2020 · Analytical and Bioanalytical Chemistry
Phase I/II randomized study of proton beam with anti-VEGF for exudative age-related macular degeneration: long-term results
Lekha K. Mukkamala, Kavita Mishra, Inder Daftari, Ala Moshiri, Susanna S. Park · 2020 · Eye
Anti-VEGF-Therapie bei fibrovaskulärer und serös-vaskularisierter Pigmentepithelabhebung bei neovaskulärer AMD
T. Barth, M. Reiners, F. Zeman, R. Greslechner, H. Helbig, M.-A. Gamulescu · 2020 · Der Ophthalmologe
Recombinant sulfated CCR2 peptide trap reduces retinal degeneration in mice
Sun‐Ah Jung, Soomin Jin, Jae‐Byoung Chae, Guk‐Heui Jo, Hyewon Chung, Jungmook Lyu, Joon‐Hyung Lee · 2021 · Biochemical and Biophysical Research Communications
Sema4D Knockout Attenuates Choroidal Neovascularization by Inhibiting M2 Macrophage Polarization Via Regulation of the RhoA/ROCK Pathway
Kaixuan Cui, Xiaoyu Tang, Boyu Yang, Matthew Fan, Andina Hu, Peiqi Wu, Fengmei Yang, Jicheng Lin, Haolin Kong, Xi Lü et al. · 2024 · Investigative Ophthalmology & Visual Science
Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration
Murat Karaçorlu, Mümin Hocaoğlu, Serra Arf, Mehmet Giray Ersöz, Işıl Sayman Muslubaş · 2019 · Turkish Journal of Ophthalmology
Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials
Hong Sun, Ling Li, Fengjiao Bu, Xiu Lan Xin, Jingchao Yan, Taomin Huang · 2024 · Eye
VISUAL OUTCOMES AND CLINICAL FEATURES OF EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN
Letícia Oliveira Audi, Ricardo A P De Carvalho, Antônio Casella, Lourdes Aiko H. Maniero, Cláudio Zett, André Marcio Vieira Messias, Fabrício Tadeu Borges, Francyne Veiga Reis Cyrino, Theodomiro Garrido, Thaís Bastos et al. · 2025 · Retina
Efficacy and Safety of Intravitreal Faricimab in Age-Related Macular Degeneration—A Review
Chih-Cheng Chan, Pei‐Kang Liu, Kai‐Chun Cheng, Hung-Chi Lai, Yo‐Chen Chang · 2025 · Journal of Clinical Medicine
Inhibition of Pathological Mitochondrial Fission in Retinal Pigment Epithelium Mitigates Choroidal Neovascularization
Hiroto Yasuda, Shinsuke Nakamura, Aimi Shirakawa, Yoshiki Kuse, Masamitsu Shimazawa · 2026 · Investigative Ophthalmology & Visual Science
AGE-RELATED MACULAR DEGENERATION INJECTION FREQUENCY
Elana A. Meer, Sonia Targ, Ning Zhang, Katherine J. Hoggatt, Kala M. Mehta, Frank L. Brodie · 2023 · Retina
Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration
Joseph B. Lin, Andrea C. Santeford, Darksha Usmani, Aaditya V. Shah, Philip A. Ruzycki, Rajendra S. Apte · 2023 · Ophthalmology Science
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Seigo Yoneyama, Taiyo Shijo, Atsushi Sugiyama, Yumi Kotoda, Kenji Kashiwagi · 2024 · Retina
Exosome’s Implications in Age-Related Macular Degeneration
Ali Torkashvand, Amir Reza Hajrasouliha · 2025 · Current Eye Research
Early anatomical outcomes of faricimab vs aflibercept 2 mg in treatment-naïve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: A head-to-head comparative study in Taiwan
Chi-Chun Yang, Chang-Chi Weng, Yu-Bai Chou, Yi-Ming Huang, Tai‐Chi Lin, Shih‐Jen Chen, De‐Kuang Hwang · 2025 · Journal of the Chinese Medical Association
BETA-PERIPAPILLARY ATROPHY AND GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS
Anton M. Kolomeyer, Eli J. Smith, Ebenezer Daniel, Gui‐Shuang Ying, Wei Pan, Max Pistilli, Juan E. Grunwald, Maureen G. Maguire, Benjamin J. Kim · 2020 · Retina
Clinical outcome using a modified treat-and-extend protocol for neovascular age-related macular degeneration
Brice Nguedia Vofo, Yaacov Cnaany, Itay Chowers · 2022 · BMJ Open Ophthalmology
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Lucas W. Rowe, Robert J. Minturn, Lauren A. Burgett, Peter Bracha, Raj K. Maturi · 2023 · International Journal of Retina and Vitreous
Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration
Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e.V. (BVA) · 2023 · Klinische Monatsblätter für Augenheilkunde
Three-year follow-up study of clinical effectiveness of antiangiogenic therapy for neovascular age-related macular degeneration
А. Ж. Фурсова, Ida F. Nikulich, E. I. Dmitrieva, O G Gusarevich, Anna S. Derbeneva, M A Vasilyeva, Oyuna S. Kozhevnikova, Nataliya G. Kolosova · 2023 · Russian Annals of Ophthalmology
Incidence and risk factors of age-related macular degeneration in patients with Parkinson’s disease: a population-based study
Bora Yoon, Ho‐Seok Sa, Hwa Jung Kim · 2024 · Frontiers in Aging Neuroscience
Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration
Alexandra Warter, Anna Heinke, Melina Cavichini, Carlo Miguel B. Galang, Fritz Gerald P. Kalaw, Dirk‐Uwe Bartsch, Lingyun Cheng, William R. Freeman · 2024 · Ophthalmic surgery, lasers & imaging retina
Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
Gábor György Deák, Klaudia Birner, Bianca S. Gerendas, Georgios Mylonas, Günther Weigert, Martin Michl, Irene Steiner, Ursula Margarethe Schmidt-Erfurth · 2025 · Scientific Reports
Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome
Jae Wook Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jung Il Han, Young Ju Lew, Jae Hui Kim · 2017 · Journal of the Korean Ophthalmological Society
Stellungnahme der DOG, der RG und des BVA zur Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration
Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA) · 2020 · Klinische Monatsblätter für Augenheilkunde
Pre‐therapeutic Biomarkers for Ranibizumab Therapy among Type 2 Diabetic Patients with Diabetic Macular Edema
Suman Kalyan Paine, Chandra Kanta Bhattacharjee, Gautam Bhaduri, Subhasish Pramanik, Prasanta Kumar Borah, Jagadish Mahanta, Analabha Basu, Lakshmi Kanta Mondal · 2020 · Optometry and Vision Science
Indikationen zur intravitrealen Injektionstherapie mit Anti-VEGF für Makulaerkrankungen – Fehler vermeiden
Carsten Framme, Bernd Junker, Nicolas Feltgen, Hans Hoerauf, Nina-Antonia Striebe, J Wachtlin, Ingo Roland Volkmann · 2022 · Der Ophthalmologe
Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes
Yu Jeong Park, Gi Sung Son, Yoon Jeon Kim, June-Gone Kim, Young Hee Yoon, Joo Yong Lee · 2018 · Journal of the Korean Ophthalmological Society
Recommendations of the treat-and-extend regimen for neovascular age-related macular degeneration: 2020 updates
Alvin KH Kwok, Wai‐Ching Lam, Angie Hon Chi Fong, Nicholas SK Fung, Mary Ho, Lawrence Pui Leung Iu, Callie KL Ko, Shaheeda Mohamed, Danny SC Ng, Heather HY Tang et al. · 2021 · Hong Kong Journal of Ophthalmology
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
Alexander J. E. Foss, Rebecca Haydock, Margaret Childs, Lelia Duley, Theo Empeslidis, Sushma Dhar‐Munshi, Alan A. Montgomery, Reuben O. Ogollah, Mara Ozolins, Paul E. Tesha et al. · 2020 · BMJ Open Ophthalmology
Macular Atrophy Incidence, Progression, and Visual Acuity Effects in 5-Year Treatment of Neovascular Age-Related Macular Degeneration
Quintin R. Richardson, Youning Zhang, Michael S. Deiner, Suling T. Wang, Jonah M. Bhisitkul, Benjamin F. Arnold, Robert B. Bhisitkul · 2022 · Ophthalmic surgery, lasers & imaging retina
Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis
Se Joon Woo, Jin Ah Jung, Tae‐Hyung Kim, Inkyung Oh, Mercy Yeeun Kim, Neil M. Bressler · 2024 · Asia-Pacific Journal of Ophthalmology
How can treatment for eye disease be made easier?
Katherine Bourzac · 2025 · Nature
Two-year treatment outcomes after anti-vascular endothelial growth factor therapy in age-related macular degeneration with type 2 macular neovascularization in Japanese patients
Yosuke Fukuda, Satomi Shiose, Shoji Notomi, Yusuke Maehara, Kenichiro Mori, Sawako Hashimoto, Kumiko Kano, Keijiro Ishikawa, Koh‐Hei Sonoda · 2025 · Japanese Journal of Ophthalmology
Anti-VEGF injections and macular atrophy progression in patients with neovascular age-related macular degeneration in remission
Nehal Nailesh Mehta, Ines Doris Nagel, Akshay Prashant Agnihotri, Fritz Gerald P. Kalaw, Anna Heinke, Lingyun Cheng, Dirk‐Uwe Bartsch, William R. Freeman · 2025 · British Journal of Ophthalmology
Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting
Massimiliano Borselli, Mutasem Elfalah, Teresa Angela Trunfio, Arianna Scala, Domenico Chisari, Alessandra Mancini, Andrea Lucisano, Giovanna Carnovale-Scalzo, Vincenzo Mollace, Giovanni Improta et al. · 2025 · Ophthalmology and Therapy
Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes
Junran Sun, Mengxi Shen, Jieqiong Chen, Yidong Wu, Yongsheng Zhou, Jingyang Feng, Yuxuan Cheng, Huixun Jia, Xiaolu Yang, Yuanyuan Gong et al. · 2025 · Ophthalmology Science
Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences
Kimberly Spooner, Samantha Fraser‐Bell, Hemal Mehta, Thomas Hong, Geoffrey Broadhead, James Wong, Andrew A. Chang · 2025 · Ophthalmologica
Wide-field choroidal thickness changes after loading-phase anti-VEGF therapy in treatment-naïve neovascular AMD
Yosuke Fukuda, Shoji Notomi, Satomi Shiose, Yusuke Maehara, Kodai Yuge, Kohei Kiyohara, Yuta Yasaka, Kenichiro Mori, Keijiro Ishikawa, Yusuke Murakami et al. · 2026 · Graefe s Archive for Clinical and Experimental Ophthalmology
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study
Craig Stewart, Jaskaran Singh Bhangu, Parinita Keshav Swarnkar, Shaik Mohammed Rifat, Sarah Khalid, Ahmed Al-Janabi, Mahmoud Husseiny Awad, Gwyn Samuel Williams · 2026 · Clinical ophthalmology
Visual noise in augmented reality improves vision in age-related macular degeneration
Pratik Raul, Taehwan Lee, Richard Barry, Faran Sabeti, Jeroen J. A. van Boxtel · 2026 · npj Aging
Electroacupuncture for blindness in age-related macular degeneration: a case report
Zixiang Geng, Lele Ling, Bingrong Li, Long Yuan, Bimeng Zhang · 2022 · Acupuncture in Medicine
RWC Update: Enhanced ILM Peeling; Retinal Gene Therapy; Laser-Induced Retinal Break and Vitreous Hemorrhage
Ashish Sharma, Lihteh Wu, STEVEN M. BLOOM, Paulo Eduardo Stanga, Joaquín Sosa Lockward, Christina Y. Weng, Mohammad A. Abbas, Kourous A. Rezaei · 2023 · Ophthalmic surgery, lasers & imaging retina
Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.
Mădălina-Casiana Palfi Salavat, Edward Paul Șeclăman, Andreea-Alexandra Mușat, Mădălina Borugă, Cristina Patoni, Marius-Nicolae Popescu, Oana Elena Teodorescu, Ovidiu Mușat, Stella Ioana Popescu Patoni · 2023 · PubMed Central
Ranibizumab treatment improves the reading speed of patients with neovascular age-related macular degeneration: A nonrandomized clinical trial using the Radner reading chart
George Hayek, Dóra Reglődi, Christophe Goetz, Jean‐Marc Perone, Adrienne Csutak · 2024 · Journal Français d Ophtalmologie
Patterns of Intravitreal Injection Utilisation, Treatment Burden, and Cost Implications in a Public Ophthalmology Service: A Retrospective Audit.
Adebusola Adenike Owokole, The Operating Room Global (TORG), Thomas Ahern, Conall Hurley · 2025 · The Operating Room Global Journal
Gene Therapy for Neovascular Macular Degeneration, Diabetic Retinopathy, and Diabetic Macular Edema
Phoebe L. Mellen, Jeffrey S. Heier · 2021 · International Ophthalmology Clinics
Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years
Michelle Prasuhn, Caroline Hillers, Felix Rommel, Gabriela Riemekasten, Harald Heidecke, Khaled Nassar, Mahdy Ranjbar, Salvatore Grisanti, Aysegül Tura · 2021 · Journal of Personalized Medicine
Impact of COVID-19-related lockdown on retinal disorders treated with intravitreal injections
Manpreet Brar, Satinder Pal Singh Grewal, Dilraj Singh Grewal, Mansi M. Sharma, Mangat Ram Dogra · 2022 · Oman Journal of Ophthalmology
Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
Neesurg S. Mehta, Rodney Fong, Machelle Wilson, Kareem Moussa, Parisa Emami-Naeini, Ala Moshiri, Glenn C. Yiu, Susanna S. Park · 2023 · Clinical ophthalmology
Gene Therapy in Age-related Macular Degeneration
Henry W. Zhou, Leo A. Kim · 2025 · International Ophthalmology Clinics
Progression of Loss of Vision From Centre‐Involving Macular Atrophy in Eyes Treated for nAMD
Kelvin Yi Chong Teo, Theodorus Leonardus Ponsioen, Sioe Lan, Louise O’Toole, Carolina Arruabarrena, Richard Barry, Helena Brosa Morros, Charmaine Chung, Alessandro Invernizzi, Chui Ming Gemmy Cheung et al. · 2025 · Clinical and Experimental Ophthalmology
Six-month outcomes of half-fluence photodynamic therapy combined with intravitreal Aflibercept injection for pachychoroid neovasculopathy
Yosuke Fukuda, Satomi Shiose, Shoji Notomi, Yusuke Maehara, Kenichiro Mori, Kumiko Kano, Keijiro Ishikawa, Koh‐Hei Sonoda · 2025 · Graefe s Archive for Clinical and Experimental Ophthalmology
Whither (or Wither) Adherence to Retina Trial Protocols in Clinical Practice?
Darius M. Moshfeghi · 2017 · Ophthalmic surgery, lasers & imaging retina
Past and prognosis of anti-VEGF therapy for wet age-related macular degeneration—the future has begun
Justus Gerhard Garweg, Johanna J. Zirpel, Christin Gerhardt, Isabel B. Pfister · 2018 · Graefe s Archive for Clinical and Experimental Ophthalmology
The Role of the VEGF Signaling Pathway in Tumor Angiogenesis
Napoleone Ferrara · 2019 · Springer eBooks
Anti-VEGF Treatment and Optical Coherence Tomography Biomarkers in Wet Age-Related Macular Degeneration
Maja Vinković, Andrijana Kopić, Tvrtka Benašić · 2021 · IntechOpen eBooks
Hypo-angiogenesis: A possible pathological factor in the development of dry age-related macular degeneration and a novel therapeutic target
Pradeep Venkatesh · 2022 · Medical Hypothesis Discovery & Innovation in Ophthalmology
Pharmacotherapy of Age-Related Macular Degeneration
Inês Laíns, Ivana K. Kim, Deeba Husain · 2022 · Springer eBooks
Do automotive window films affect drivers’ safety by decreasing vision sensitivity? A Cross-sectional study
Carolina do Val Ferreira Ramos, Luciana Piacente Pap, Deborah Reuter Amaral Chivante, Larissa Maria Prodocimo, Aileen Walsh, Camilla Walsh Crema, Armando Stefano Crema, Paulo Schor · 2022 · Revista Brasileira de Oftalmologia
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
Clement K. Chan, Wesley T. Beaulieu, Brandon J. Lujan, Maziar Lalezary, Daniella Lent-Schochet, Therlinder Lo, Glenn C. Yiu · 2023 · Translational Vision Science & Technology
36-Month Evaluation of Intravitreous Aflibercept Injection for Wet Age-Related Macular Degeneration in Patients Previously Treated With Ranibizumab or Bevacizumab
Felipe F. Conti, Fabiana Queiroga de Paula Araujo Silva, Sunil K. Srivastava, Justis P. Ehlers, ANDREW P. SCHACHAT, Rishi P. Singh · 2018 · Ophthalmic surgery, lasers & imaging retina
Treat-and-extend regimens with anti-vascular endothelial growth factor agents in age-related macular degeneration
Siqing Yu, René Rückert, Marion Ronit Munk · 2019 · Expert Review of Ophthalmology
Development of a Patient-Oriented Organizational Management System for Intravitreal Injection Therapy in a Standardized “Treat-and-Extend” Regime at a University Eye Clinic
Carsten Framme, Oliver Greb, Sascha Bayer, Pascal Buley, Amelie Pielen, Katerina Hufendiek, Bernd Junker, Ingo Roland Volkmann · 2020 · Klinische Monatsblätter für Augenheilkunde
Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration? A Prospective, Randomized, Pilot Study
Sharon D. Solomon, Victoria Kyerematen, Madiha Qutab, Adam S. Wenick, Jiangxia Wang, Barbara S. Hawkins · 2021 · Clinical ophthalmology
Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process
Alfredo García‐Layana, Gerhard Garhöfer, Tariq Mehmood Aslam, Rufino Martins da Silva, Cécile Delcourt, Caroline C. W. Klaver, Johanna M. Seddon, Angelo Maria Minnella · 2021 · Journal of Clinical Medicine
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Sean D. Adrean, Darren K. Knight, Siyang Chaili, Hema L. Ramkumar, Ash Pirouz, Scott Grant · 2022 · International Journal of Retina and Vitreous
Recent Advances and New Perspectives in Managing Macular Degeneration
Pinakin Gunvant Davey · 2021 · IntechOpen eBooks
Umstellung des Therapieschemas pro re nata (PRN) auf Treat and Extend (T&E) in der intravitrealen Therapie mit Anti-VEGF-Medikamenten in der Praxis oder kleineren Institutionen
Pascal D. Imesch, Gian‐Marco Sarra · 2016 · Klinische Monatsblätter für Augenheilkunde
Tratamiento con fármacos antiangiogénicos de la degeneración macular asociada a la edad exudativa: análisis de la función visual a largo plazo en la práctica clínica habitual
Ana Palazón-Cabanes, Begona Palazón-Cabanes, Inmaculada Sellés-Navarro · 2020 · Revista Mexicana de Oftalmología
Targeted Management of Excess Specialty Spending: The Case of Biologics for Retinal Disease
Helena Moon, Julian A. Mitton, Amanda Redmond, Nicholas W. Stine · 2022 · NEJM Catalyst
Evolution and Advances in Wet Age-Related Macular Degeneration Treatments
Samantha R. Goldburg, George Jiao, Ronni M. Lieberman · 2023 · Advances in Ophthalmology and Optometry
LONG-TERM USE OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Tedi Begaj, Daeun Jeong, Jong G. Park, Margaret McDougal Runner, Antonio Capone, A. Bawa Dass, Kimberly A. Drenser, Lisa J. Faia, Nathan D. Farley, Bruce R. Garretson et al. · 2023 · Retina
Enhanced retinal pigment epithelial cells as a delivery vehicle for retinal disease
Avril Reddy, Chris Greene, Yosuke Hashimoto, Anna‐Sophia Kiang, Natalie Hudson, Peter Adamson, Tiago Santos‐Ferreira, Matthew Campbell · 2025 · Molecular Therapy — Methods & Clinical Development
Long-term outcomes of the observe-and-plan regimen in treating neovascular age-related macular degeneration: a retrospective real-life analysis
Mohamed Mamdouh Sherif, Yasmine Derradji, A. Safi, Irmela Mantel · 2025 · Eye
Automated fluid monitoring to optimize the follow-up of neovascular age-related macular degeneration patients in the Brazilian population
Virgínia Mares, Gregor Sebastian Reiter, Aniel Feitosa, Markus Gumpinger, Hrvoje Bogunović, Ursula Margarethe Schmidt-Erfurth, Márcio Bittar Nehemy · 2025 · International Journal of Retina and Vitreous
Additional Effects of Faricimab in Aflibercept Low-Responders: Retinal Morphology and Function in Eyes with Neovascular Age Related Macular Degeneration Following a Switch Between Two Anti-VEGF Agents
Jan Rothbächer, Haidar Khalil, Markus Eidherr, Matthias Bolz · 2025 · Clinical ophthalmology
Epac1 deletion attenuates Müller glial pathological activation and mitigates retinal neurodegeneration in ischemia-induced retinopathy
Shuizhen Shi, Fan Xia, Zhongqiao Lu, Erick Palacios, Fang C. Mei, Massoud Motamedi, Xiaodong Cheng, Hua Liu, Wenbo Zhang · 2025 · Journal of Advanced Research
Air pollution and the eye: A hypothesis to neural damage
Monique Matsuda, Ian Mudway · 2025 · Experimental Eye Research
Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness
Seung Yeon Lee, Daniel Duck-Jin Hwang · 2025 · Journal of Clinical Medicine
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study
Sunil S Patel, David Boyer, Anat Loewenstein, Julie Clark, Liansheng Zhu, Justin Tang, Dhaval Desai · 2026 · BMJ Open Ophthalmology
RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD
Iori Wada, Keijiro Ishikawa, Muneo Yamaguchi, Shotaro Shimokawa, Ji Rui, Kenichiro Mori, Yoshihiro Kaizu, Mitsuru Arima, Shoji Notomi, Yusuke Murakami et al. · 2026 · Investigative Ophthalmology & Visual Science
Bevacizumab for blinding eye disease – is it time for the PBS to list for off-label use?
Peter Heyworth · 2022 · Australian Health Review
Consensus on managing center-involving diabetic macular edema in Hong Kong: perspective
Nicholas Siu Kay Fung, Mary Ho, Chui Ming Gemmy Cheung, Alvin KH Kwok, Gary KY Lee, Danny SC Ng, Pui Pui Yip, Raymond L. M. Wong, Timothy Y. Y. Lai · 2024 · Hong Kong Journal of Ophthalmology
MicroRNA-34a suppresses KLF2 to promote pathological angiogenesis through the CXCR4/CXCL12 pathway in age-related macular degeneration
Jason J. Colasanti, Andrea C. Santeford, Joseph B. Lin, Ryo Terao, Tae Jun Lee, Rajendra S. Apte · 2026 · Proceedings of the National Academy of Sciences
The Fight Retinal Blindness! registry: An international treatment outcomes registry for retinal diseases
Yohei Hashimoto, Daniel Barthelmes, Mark C. Gillies · 2025 · Annals of Clinical Epidemiology
Efficacy of Intravitreal Conbercept in Vitrectomy for Proliferative Diabetic Retinopathy: An Integrated Meta-Analysis and Bibliometric Study
Guangda Li, Mingxuan Zhang, Yifeng Ke, Chuanzhen Zheng, Liangzhang Tan, Yongtao Li, Emmanuel Eric Pazo, Chunli Chen, Xinjun Ren · 2025 · Clinical ophthalmology
The Future of Treatment for Wet AMD
Shilpa J. Desai, Elias Reichel · 2017 · Current Ophthalmology Reports
Centenarians With Age-Related Macular Degeneration
Maxwell S. Stem, Danny A. Mammo, Yoshihiro Yonekawa, Bozho Todorich, Benjamin J. Thomas, George A. Williams · 2017 · Journal of VitreoRetinal Diseases
Die Frage nach Zusammenhängen in multivariaten Datensätzen zur Behandlung der nvAMD
Robert G. H. Wilke, Robert Patrick Finger, Helmut G. Sachs · 2017 · Klinische Monatsblätter für Augenheilkunde
Estudio del fluido tomográfico y concordancia en su detección entre médicos residentes en pacientes näive con degeneración macular asociada a la edad (DMAE) neovascular
M.M. Alberto-Pestano, C. Piñero-Cutillas, Rodrigo Abreu González · 2020 · Archivos de la Sociedad Española de Oftalmología
Extent and Process of 'Silent Exclusion' in Elementary Education: A Case Study of Madhya Pradesh
Pankaj Kumar Das · 2011 · Madhya Pradesh Journal of Social Sciences
Suppression of choroidal neovascularization in mice by subretinal delivery of multigenic lentiviral vectors encoding anti-angiogenic microRNAs
Anne Louise Askou, Josephine Natalia Esther Benckendorff, Andreas Holmgaard, Tina Storm, Lars Aagaard, Toke Bek, Jacob Giehm Mikkelsen, Thomas J. Corydon · 2017 · Human Gene Therapy Methods
Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization
Aniket Ramshekar, Colin A. Bretz, Eric Kunz, Thaonhi Cung, Burt T. Richards, Gregory J. Stoddard, Gregory S. Hageman, Brahim Chaqour, M. Elizabeth Hartnett · 2022 · Biomedicines
Towards the Development of Longer and More Efficacious Therapies for Wet and Dry Age-related Macular Degeneration
Alessandro Arrigo, Francesco Maria Bandello · 2022 · touchREVIEWS in Ophthalmology
Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903
Jingjuan Ding, Bo Li, Huiying Zhang, Zhijian Xu, Qiuyang Zhang, Rong Ye, Si-Guo Feng, Qin Li Jiang, Weiliang Zhu, Biao Yan · 2022 · Translational Vision Science & Technology
Long-Term Visual Outcomes in Neovascular Age-Related Macular Degeneration Eyes With Baseline Macular Atrophy on Anti-Vascular Endothelial Growth Factor Treatment
Michael J. Foster, Jacqueline K. Shaia, Christopher M. Maatouk, Catherine A. Urbano, Mark T. Bui, Grant L. Hom, Blanche L. Kuo, Rishi P. Singh, Katherine E. Talcott · 2023 · Ophthalmic surgery, lasers & imaging retina